PANX1 and inflammatory bowel disease: We also examined compound 12 as a proof‐of‐concept approach for treating IBD by using a dextran sodium sulfate (DSS)‐induced mouse model of colitis, further underscoring the potentials of new PANX1 inhibitors in basic and translational research.